Mitomycin-C plus metronidazole in advanced carcinoma of the breast
β Scribed by David J Stewart; Jean A Maroun; Bernard Lefebvre; Richard Heringer; Alfred F Crook
- Publisher
- Springer US
- Year
- 1985
- Tongue
- English
- Weight
- 544 KB
- Volume
- 5
- Category
- Article
- ISSN
- 0167-6806
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Forty-six patients with far-advanced malignancies, primarily of epithelial origin, were treated with intravenously administered mitomycin-C over a 4-year period. Several patients received more than one course of therapy. Thirty per cent of the patients demonstrated a transient, objective remission a
In a Phase I1 study, 50 patients with advanced breast cancer were treated with a combination of 5fluorouracil(lOO0 mg/m2 on days 1 and 2) and mitomycin C (6 mg/m2 on day 2) (FuMi regimen). The courses were repeated every third to sixth week. Although 35 patients had previously received combination c